Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT. (Q43233993)

16 November 2017

title

Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT. (English)

1 reference

16 November 2017

0 references

invasive aspergillosis

1 reference

S S Egger

1 reference

16 November 2017

S Meier

1 reference

16 November 2017

C Leu

1 reference

16 November 2017

S Christen

1 reference

16 November 2017

A Gratwohl

1 reference

16 November 2017

S Krähenbühl

1 reference

16 November 2017

M Haschke

1 reference

16 November 2017

language of work or name

English

0 references

publication date

30 November 2009

1 reference

Bone Marrow Transplantation

16 November 2017

published in

1 reference

16 November 2017

1 reference

16 November 2017

1 reference

16 November 2017

page(s)

1197-1203

1 reference

Aspergillus infections in transplant recipients

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Patients at high risk of invasive fungal infections: when and how to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Amphotericin B lipid preparations: what are the differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Lipid-based amphotericin B formulations: from animals to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Combination antifungal therapy: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

21 January 2018

Adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Antifungal agents--clinical pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Fungal infections in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Interpretation of serum calcium in patients with abnormal serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Optimizing the use of cyclosporin in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Voriconazole: in the treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Clinical relevance of sirolimus drug interactions in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

Potential drug-drug interactions in the medication of medical patients at hospital discharge

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

Drug-drug interactions with systemic antifungals in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.325

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.325

1 reference

Dimensions Publication ID

16 November 2017

1029832689

0 references

1 reference